MetaADEDB 2.0 @ LMMD
Methylprednisolone Hemisuccinate
(IMBXEJJVJRTNOW-XYMSELFBSA-N)
Structure
SMILES
OC(=O)CCC(=O)OCC(=O)[C@@]1(O)CC[C@@H]2[C@]1(C)C[C@H](O)[C@H]1[C@H]2C[C@@H](C2=CC(=O)C=C[C@]12C)C
Type(s)
Approved
Molecular Formula:
C26H34O8
Molecular Weight:
474.543
Log P:
2.2193
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
3
TPSA:
138.2
CAS Number(s):
2921-57-5
Synonym(s)
1.
Methylprednisolone Hemisuccinate
2.
Methylprednisolone Succinate
3.
6 alpha-Methylprednisolone Sodium Hemisuccinate
4.
A-MethaPred
5.
Methylprednisolone Hemisuccinate Monosodium Salt
6.
Methylprednisolone Sodium Hemisuccinate
7.
Methylprednisolone Sodium Succinate
8.
Solu-Medrol
9.
Solumedrol
10.
Urbason-Soluble
11.
Hemisuccinate, Methylprednisolone
12.
Sodium Hemisuccinate, Methylprednisolone
13.
Sodium Succinate, Methylprednisolone
14.
Succinate, Methylprednisolone
15.
UrbasonSoluble
External Link(s)
MeSHD008776
PubChem Compound16923
ChEBI135765
CHEMBLCHEMBL1201265
DrugBankDB14644
DrugCentral1771
KEGGdr:D05000
ZINC3977781
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1HypersensitivityFAERS: 31US FAERS
2UrticariaFAERS: 28US FAERS
3PruritusFAERS: 27US FAERS
4ErythemaFAERS: 2412921496CTD
US FAERS
5Anaphylactic shockFAERS: 22US FAERS
6AstheniaFAERS: 18US FAERS
7FlushingFAERS: 17US FAERS
8Blood glucose increasedFAERS: 15US FAERS
9PainFAERS: 15US FAERS
10ShockFAERS: 13US FAERS
11TachycardiaFAERS: 13US FAERS
12DizzinessFAERS: 12US FAERS
13AsthmaFAERS: 11US FAERS
14Injection site painFAERS: 11US FAERS
15MalaiseFAERS: 10US FAERS
16VomitingFAERS: 103542325
12921496
CTD
US FAERS
17Cardiac ArrestFAERS: 9US FAERS
18Chest PainFAERS: 9US FAERS
19AnxietyFAERS: 8US FAERS
20ChillsFAERS: 812921496CTD
US FAERS
21FatigueFAERS: 8US FAERS
22Respiratory distressFAERS: 8US FAERS
23AgitationFAERS: 7US FAERS
24HypotensionFAERS: 712921496CTD
US FAERS
25Product quality issueFAERS: 7US FAERS
26Burning sensationFAERS: 6US FAERS
27Diabetes MellitusFAERS: 6US FAERS
28Drug ineffectiveFAERS: 6US FAERS
29NervousnessFAERS: 6US FAERS
30PalpitationsFAERS: 6US FAERS
31PancreatitisFAERS: 6US FAERS
32Pharmaceutical product complaintFAERS: 6US FAERS
33Respiratory FailureFAERS: 6US FAERS
34TremorFAERS: 6US FAERS
35WheezingFAERS: 6US FAERS
36DysgeusiaFAERS: 5US FAERS
37Injection site abscessFAERS: 5US FAERS
38Intestinal PerforationFAERS: 5US FAERS
39Medication ErrorFAERS: 5US FAERS
40Rash erythematousFAERS: 5US FAERS
41Respiratory arrestFAERS: 5US FAERS
42SyncopeFAERS: 5US FAERS
43AngioedemaFAERS: 4US FAERS
44Back PainFAERS: 4US FAERS
45BlindnessFAERS: 4US FAERS
46BradycardiaFAERS: 4US FAERS
47BronchospasmFAERS: 4US FAERS
48Chest discomfortFAERS: 4US FAERS
49Disseminated Intravascular CoagulationFAERS: 4US FAERS
50Initial insomniaFAERS: 4US FAERS
51Multiple SclerosisFAERS: 48326337CTD
US FAERS
52NauseaFAERS: 43542325CTD
US FAERS
53RestlessnessFAERS: 4US FAERS
54Anaphylactoid ReactionFAERS: 3US FAERS
55ArthritisFAERS: 3US FAERS
56Blood creatinine increasedFAERS: 3US FAERS
57Bone density decreasedFAERS: 3US FAERS
58Cerebral InfarctionFAERS: 3US FAERS
59Cold sweatFAERS: 3US FAERS
60Depressed Level of ConsciousnessFAERS: 3US FAERS
61Gastric ulcerFAERS: 3US FAERS
62Incorrect dose administeredFAERS: 3US FAERS
63Injection site movement impairmentFAERS: 3US FAERS
64MeningitisFAERS: 3US FAERS
65MyalgiaFAERS: 3US FAERS
66Myocardial InfarctionFAERS: 33527810CTD
US FAERS
67PallorFAERS: 3US FAERS
68PneumoniaFAERS: 3US FAERS
69Reaction to drug excipientsFAERS: 3US FAERS
70Skin test positiveFAERS: 3US FAERS
71SneezingFAERS: 3US FAERS
72SwellingFAERS: 3US FAERS
73Therapy non-responderFAERS: 3US FAERS
74ThrombocytopeniaFAERS: 3US FAERS
75Urinary IncontinenceFAERS: 3US FAERS
76nervous system disorderFAERS: 3US FAERS
77AbasiaFAERS: 2US FAERS
78Abdominal PainFAERS: 2US FAERS
79Angina PectorisFAERS: 2US FAERS
80AnuriaFAERS: 2US FAERS
81ArthralgiaFAERS: 212921496CTD
US FAERS
82Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
83Atrial FibrillationFAERS: 212921496CTD
US FAERS
84Blood pressure immeasurableFAERS: 2US FAERS
85CataractFAERS: 2US FAERS
86Cerebral ThrombosisFAERS: 2US FAERS
87CyanosisFAERS: 2US FAERS
88Cytolytic hepatitisFAERS: 2US FAERS
89DeliriumFAERS: 2US FAERS
90Drug effect delayedFAERS: 2US FAERS
91EmbolismFAERS: 2US FAERS
92EpilepsyFAERS: 2US FAERS
93ErysipelasFAERS: 2US FAERS
94Euphoric moodFAERS: 2US FAERS
95Eye painFAERS: 2US FAERS
96Eyelids pruritusFAERS: 2US FAERS
97Feeling abnormalFAERS: 2US FAERS
98HeadacheFAERS: 2US FAERS
99HemiplegiaFAERS: 2US FAERS
100Impaired work abilityFAERS: 2US FAERS
101IncoherentFAERS: 2US FAERS
102Incorrect route of drug administrationFAERS: 2US FAERS
103Increased upper airway secretionFAERS: 2US FAERS
104Injection site infectionFAERS: 2US FAERS
105Lip swellingFAERS: 2US FAERS
106LymphadenopathyFAERS: 2US FAERS
107Myasthenic SyndromeFAERS: 2US FAERS
108MyositisFAERS: 2US FAERS
109Nerve injuryFAERS: 2US FAERS
110NystagmusFAERS: 2US FAERS
111Ocular HypertensionFAERS: 2US FAERS
112OsteomyelitisFAERS: 2US FAERS
113OverdoseFAERS: 2US FAERS
114Pancreatic InsufficiencyFAERS: 2US FAERS
115Pharyngolaryngeal PainFAERS: 2US FAERS
116Post procedural infectionFAERS: 2US FAERS
117PresyncopeFAERS: 2US FAERS
118Product container issueFAERS: 2US FAERS
119Protein total decreasedFAERS: 2US FAERS
120Psychiatric symptomFAERS: 2US FAERS
121Pulmonary EmbolismFAERS: 2US FAERS
122Retinal infarctionFAERS: 2US FAERS
123Rheumatoid ArthritisFAERS: 2US FAERS
124SchizophreniaFAERS: 2US FAERS
125Skin UlcerFAERS: 2US FAERS
126SomnolenceFAERS: 2US FAERS
127Throat irritationFAERS: 2US FAERS
128Unresponsive to stimuliFAERS: 2US FAERS
129Upper airway obstructionFAERS: 2US FAERS
130Urinary RetentionFAERS: 2US FAERS
131Urinary tract infectionFAERS: 2US FAERS
132Venous thrombosis limbFAERS: 2US FAERS
133Ventricular FibrillationFAERS: 2US FAERS
134Visual ImpairmentFAERS: 2US FAERS
135Wound dehiscenceFAERS: 2US FAERS
136AbscessFAERS: 1US FAERS
137Acute myocardial infarctionFAERS: 1US FAERS
138Alanine aminotransferase decreasedFAERS: 1US FAERS
139AlopeciaFAERS: 1US FAERS
140AngerFAERS: 1US FAERS
141Anorectal discomfortFAERS: 1US FAERS
142Application site discomfortFAERS: 1US FAERS
143Aspartate aminotransferase decreasedFAERS: 1US FAERS
144Autoimmune hepatitisFAERS: 1US FAERS
145Biopsy heart abnormalFAERS: 1US FAERS
146Bipolar DisorderFAERS: 1US FAERS
147Blood albumin decreasedFAERS: 1US FAERS
148Blood creatine phosphokinase increasedFAERS: 1US FAERS
149Blood lactate dehydrogenase increasedFAERS: 1US FAERS
150Blood pressure fluctuationFAERS: 1US FAERS
151Blood urea increasedFAERS: 1US FAERS
152Blood urine presentFAERS: 1US FAERS
153BronchitisFAERS: 1US FAERS
154Carbon dioxide increasedFAERS: 1US FAERS
155CardiomegalyFAERS: 1US FAERS
156Cerebrovascular accidentFAERS: 1US FAERS
157CholestasisFAERS: 1US FAERS
158ColitisFAERS: 1US FAERS
159Complement factor C3 decreasedFAERS: 1US FAERS
160Complement factor C4 decreasedFAERS: 1US FAERS
161Complement factor abnormalFAERS: 1US FAERS
162Completed SuicideFAERS: 1US FAERS
163ConstipationFAERS: 1US FAERS
164Contrast media reactionFAERS: 1US FAERS
165Corneal dystrophyFAERS: 1US FAERS
166CryingFAERS: 1US FAERS
167CystitisFAERS: 1US FAERS
168Cytomegalovirus test positiveFAERS: 1US FAERS
169DeafnessFAERS: 1US FAERS
170Depressed moodFAERS: 1US FAERS
171Device FailureFAERS: 1US FAERS
172Diabetic KetoacidosisFAERS: 1US FAERS
173DiscomfortFAERS: 1US FAERS
174Disease ProgressionFAERS: 1US FAERS
175Disease recurrenceFAERS: 1US FAERS
176Dissociative disorderFAERS: 1US FAERS
177Drug administration errorFAERS: 1US FAERS
178DyscheziaFAERS: 1US FAERS
179DyspepsiaFAERS: 1US FAERS
180DysphoniaFAERS: 1US FAERS
181DysuriaFAERS: 1US FAERS
182Electrocardiogram abnormalFAERS: 1US FAERS
183Endocarditis enterococcalFAERS: 1US FAERS
184Epidermolysis BullosaFAERS: 1US FAERS
185ErythrosisFAERS: 1US FAERS
186Feeling ColdFAERS: 1US FAERS
187FractureFAERS: 1US FAERS
188Gastrointestinal perforationFAERS: 1US FAERS
189General physical health deteriorationFAERS: 1US FAERS
190Hepatic necrosisFAERS: 1US FAERS
191Hepatic vein occlusionFAERS: 1US FAERS
192Hepatitis BFAERS: 1US FAERS
193HepatitisFAERS: 1US FAERS
194HepatomegalyFAERS: 1US FAERS
195Hypertensive crisisFAERS: 1US FAERS
196HyperthyroidismFAERS: 1US FAERS
197HyperventilationFAERS: 1US FAERS
198HypothyroidismFAERS: 1US FAERS
199HypoventilationFAERS: 1US FAERS
200HypoxiaFAERS: 1US FAERS
201Incorrect storage of drugFAERS: 1US FAERS
202InfectionFAERS: 1US FAERS
203Infrequent bowel movementsFAERS: 1US FAERS
204Infusion site painFAERS: 1US FAERS
205Infusion site pruritusFAERS: 1US FAERS
206Infusion site reactionFAERS: 1US FAERS
207Injection site erythemaFAERS: 1US FAERS
208Injection site necrosisFAERS: 1US FAERS
209Injection site phlebitisFAERS: 1US FAERS
210Irritable Bowel SyndromeFAERS: 1US FAERS
211Lactose IntoleranceFAERS: 1US FAERS
212LaryngospasmFAERS: 1US FAERS
213LeukocytosisFAERS: 1US FAERS
214LeukopeniaFAERS: 1US FAERS
215Lung consolidationFAERS: 1US FAERS
216Lupus NephritisFAERS: 1US FAERS
217LymphangitisFAERS: 1US FAERS
218Lymphocyte stimulation test positiveFAERS: 1US FAERS
219Lymphocytic infiltrationFAERS: 1US FAERS
220LymphopeniaFAERS: 1US FAERS
221Markedly reduced dietary intakeFAERS: 1US FAERS
222Mechanical ventilationFAERS: 1US FAERS
223Medical device complicationFAERS: 1US FAERS
224Medication dilutionFAERS: 1US FAERS
225Mental status changesFAERS: 1US FAERS
226Multiple sclerosis relapseFAERS: 1US FAERS
227Muscle necrosisFAERS: 1US FAERS
228Musculoskeletal PainFAERS: 1US FAERS
229Myasthenia GravisFAERS: 1US FAERS
230MyopathyFAERS: 1US FAERS
231NecrosisFAERS: 1US FAERS
232No adverse eventFAERS: 1US FAERS
233Optic AtrophyFAERS: 1US FAERS
234Oropharyngeal discomfortFAERS: 1US FAERS
235OsteoporosisFAERS: 1US FAERS
236Pancreatic enlargementFAERS: 1US FAERS
237PancytopeniaFAERS: 1US FAERS
238ParaparesisFAERS: 1US FAERS
239PneumothoraxFAERS: 1US FAERS
240PoisoningFAERS: 1US FAERS
241Postoperative infectionFAERS: 1US FAERS
242Procedural complicationFAERS: 1US FAERS
243Product lot number issueFAERS: 1US FAERS
244Rash scalyFAERS: 1US FAERS
245Red man syndromeFAERS: 1US FAERS
246Renal painFAERS: 1US FAERS
247Retinal DetachmentFAERS: 1US FAERS
248Retinal VasculitisFAERS: 1US FAERS
249SciaticaFAERS: 1US FAERS
250Scleroderma renal crisisFAERS: 1US FAERS
251SepsisFAERS: 1US FAERS
252Septic ShockFAERS: 1US FAERS
253Sinus ArrhythmiaFAERS: 1US FAERS
254SluggishnessFAERS: 1US FAERS
255Spastic ParaplegiaFAERS: 1US FAERS
256Status AsthmaticusFAERS: 1US FAERS
257StomatitisFAERS: 1US FAERS
258StridorFAERS: 1US FAERS
259StuporFAERS: 1US FAERS
260Sudden infant death syndromeFAERS: 1US FAERS
261Thrombocytopenic purpuraFAERS: 1US FAERS
262Tooth LossFAERS: 1US FAERS
263TuberculosisFAERS: 1US FAERS
264Unevaluable eventFAERS: 1US FAERS
265Urine ketone body presentFAERS: 1US FAERS
266White blood cell count decreasedFAERS: 1US FAERS
267Wrong technique in drug usage processFAERS: 1US FAERS
268Chemical and Drug Induced Liver Injury3800520CTD
269Dyspnea12921496CTD
270Fever12921496CTD
271Optic Neuritis14552184CTD
272Paraplegia23452429CTD
273Pemphigus7657447CTD
274Pyelonephritis2256750CTD
275Respiratory Syncytial Virus Infections15262687CTD
276Rhabdomyolysis12921496CTD
277Spinal Cord Injuries17184187
23452429
CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.